Technical Analysis for SELB - Selecta Biosciences, Inc.

Grade Last Price % Change Price Change
D 3.79 -3.56% -0.14
SELB closed down 1.26 percent on Thursday, April 15, 2021, on 36 percent of normal volume.
Earnings due: May 1
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical SELB trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish -3.56%
Oversold Stochastic Weakness -3.56%
Oversold Stochastic Weakness -4.77%
Stochastic Reached Oversold Weakness -2.82%
Lower Bollinger Band Touch Weakness -2.82%
Oversold Stochastic Weakness -2.82%
Below Lower BB Weakness -0.26%
Lower Bollinger Band Touch Weakness -0.26%
MACD Bearish Centerline Cross Bearish -9.33%
180 Bearish Setup Bearish Swing Setup -9.33%
Older End-of-Day Signals for SELB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 2 hours ago
60 Minute Opening Range Breakdown about 2 hours ago
Down 2 % about 2 hours ago
Fell Below Previous Day's Low about 2 hours ago
Down 1% about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Selecta Biosciences, Inc., a clinical-stage biotechnology company, develops targeted therapies that use immunomodulators encapsulated in nanoparticles to induce antigen-specific immune responses to prevent and treat disease. The company focus is on developing and commercializing differentiated therapies that are designed to modulate the immune system to effectively and safely treat rare diseases by mitigating the formation of anti-drug antibodies in response to life-sustaining biologic drugs. Its lead product candidate is SEL-212 for the treatment of refractory and chronic tophaceous gout. The company serves customers in the United States and internationally. Selecta Biosciences, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Immune System Disease Immunotherapy Antibodies Rare Diseases Cancer Treatments Virotherapy Antibody Immune Response Gout

Is SELB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.7
52 Week Low 1.4701
Average Volume 1,483,918
200-Day Moving Average 3.23
50-Day Moving Average 4.36
20-Day Moving Average 4.25
10-Day Moving Average 4.15
Average True Range 0.26
ADX 13.66
+DI 23.12
-DI 27.37
Chandelier Exit (Long, 3 ATRs ) 4.08
Chandelier Exit (Short, 3 ATRs ) 4.55
Upper Bollinger Band 4.76
Lower Bollinger Band 3.74
Percent B (%b) 0.19
BandWidth 24.07
MACD Line -0.08
MACD Signal Line -0.03
MACD Histogram -0.05
Fundamentals Value
Market Cap 424.56 Million
Num Shares 108 Million
EPS -1.85
Price-to-Earnings (P/E) Ratio -2.13
Price-to-Sales 24.96
Price-to-Book 31.26
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.17
Resistance 3 (R3) 4.17 4.10 4.13
Resistance 2 (R2) 4.10 4.04 4.10 4.12
Resistance 1 (R1) 4.01 4.00 3.98 4.01 4.10
Pivot Point 3.94 3.94 3.92 3.94 3.94
Support 1 (S1) 3.85 3.88 3.82 3.85 3.76
Support 2 (S2) 3.78 3.84 3.78 3.74
Support 3 (S3) 3.69 3.78 3.73
Support 4 (S4) 3.69